Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Citations Over TimeTop 1% of 2017 papers

Abstract

Multidrug-resistant tuberculosis (MDR-TB), caused by drug-resistant strains of Mycobacterium tuberculosis, is an increasingly serious problem worldwide. Here we examined a data set of whole-genome sequences from 5,310 M. tuberculosis isolates from five continents. Despite the great diversity of these isolates with respect to geographical point of isolation, genetic background and drug resistance, the patterns for the emergence of drug resistance were conserved globally. We have identified harbinger mutations that often precede multidrug resistance. In particular, the katG mutation encoding p.Ser315Thr, which confers resistance to isoniazid, overwhelmingly arose before mutations that conferred rifampicin resistance across all of the lineages, geographical regions and time periods. Therefore, molecular diagnostics that include markers for rifampicin resistance alone will be insufficient to identify pre-MDR strains. Incorporating knowledge of polymorphisms that occur before the emergence of multidrug resistance, particularly katG p.Ser315Thr, into molecular diagnostics should enable targeted treatment of patients with pre-MDR-TB to prevent further development of MDR-TB.

Related Papers

• → Quantification of pyrazinamide, isoniazid, acetyl‐isoniazid, and rifampicin by a high‐performance liquid chromatography method in human plasma from patients with tuberculosis(2020)19 cited
• FORMULATION AND EVALUATION OFENTERIC COATED PELLETS OF RIFAMPICIN AND ISONIAZID WITH IMPROVED RIFAMPICIN STABILITY(2014)
• Effect of Rifampicin and Isoniazid Coadministration on the Metabolism and Pharmacokinetics of Isoniazid in Mice(2011)
• Effects of Aminosalicylic Acid on Peak Blood Concentration of Rifampicin(2012)
• Interaksi Metabolisme INH & Rifampisin Menggunakan Hepatosit Tikus(2000)